newsfilter
← Latest News
ACCESS Newswire·

MIRA Pharmaceuticals' Lead Drug Candidate Ketamir-2 First Manuscript Accepted for Publication in the Peer-Reviewed Journal Frontiers in Pharmacology

MIAMI, FL / ACCESS Newswire / June 18, 2025 / MIRA Pharmaceuticals, Inc. , a clinical-stage pharmaceutical company developing novel therapeutics for neurologic,